Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

IBM Launches New Solution for Emerging Field of Personalized Medicine

26.07.2004


IBM Clinical Genomics Solution Provides the Technology Infrastructure to Help Accelerate Information-Based Medicine

IBM today announced a new information technology (IT) solution designed to assist medical researchers and physicians bridge the gap between clinical research and patient care. By offering services and technology to identify the molecular mechanisms of disease and ultimately develop more personalized medicine, the IBM Healthcare and Life Sciences Clinical Genomics Solution is designed to further information-based medicine, a new way in which healthcare is developed and delivered.

The IBM Healthcare and Life Sciences Clinical Genomics Solution enables research institutions and biopharmaceutical companies across the world to integrate, store, analyze and better understand genotypic and phenotypic data for medical research and patient care. Critical components of the solution include business consultant services, business strategy and process re-engineering, and:



The Medical Information: interfaces with hospital and research systems to capture and de-identify information from each patient or research encounter, helping to ensure patient security and privacy

The Medical Information Broker: pulls data from multiple healthcare institutions and diagnostic laboratories to be stored in the Medical Information Repository

The Medical Information Repository: centralizes data for integrated clinical and high-throughput research, enabling an organization to fully leverage its information assets

IBM DB2 ® Information Integrator: Helps increase researchers’ productivity by providing seamless access to additional data in external databases such as Medline, dbSNP and GenBank

IBM Business Partner Platforms: complete solution through powerful technologies offered by IBM Business Partners

"Globally, healthcare is undergoing a profound transformation toward targeted therapeutics and treatment regimens. Working with our Business Partners, IBM is deeply committed to shedding light on the critical role information technology will play in personalized medicine," said Mike Svinte, vice president, information-based medicine, IBM. "We’ve built our clinical genomics services practice to aid this transformation by enhancing drug discovery and medical practices with knowledge generated from diverse clinical and biomedical data. Our new solution will help clients achieve this vision of information-based medicine by accelerating our understanding of disease."

The IBM Healthcare and Life Sciences Clinical Genomics Solution reflects IBM’s deep commitment to advancing healthcare and life sciences and leverages cutting-edge work by IBM Research as well as companies such as the Mayo Clinic and the H. Lee Moffitt Cancer Center and Research Institute.

Information-based medicine is the use of IT to cross-reference clinical information -- such as patient records, family histories and lab tests -- with knowledge about the human genome. By understanding illnesses on the molecular level, including gene variations linked to disease or drug response, doctors may be able to make more precise diagnoses and tailor treatment decisions. Similarly, drug makers can work to develop more targeted treatment therapies and identify potential clinical trail participants more effectively.

The IBM Healthcare and Life Sciences Clinical Genomics Solution can help facilitate companies’ compliance with rigorous patient privacy and security standards, such as HIPAA. Every implementation leverages IBM’s security framework, which is based on the Tivoli® suite of products. Tivoli applications help institutions define consistent security policies -- based on both internal requirements and industry standards -- and monitor compliance. Other products used in the clinical genomics solution include the IBM ® pSeries®, IBM DB2 Universal Database® and IBM WebSphere® Portal Server.

Jorge Alberni | IBM Corporation
Further information:
http://www.ibm.com

More articles from Information Technology:

nachricht Construction of practical quantum computers radically simplified
05.12.2016 | University of Sussex

nachricht UT professor develops algorithm to improve online mapping of disaster areas
29.11.2016 | University of Tennessee at Knoxville

All articles from Information Technology >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

NTU scientists build new ultrasound device using 3-D printing technology

07.12.2016 | Health and Medicine

The balancing act: An enzyme that links endocytosis to membrane recycling

07.12.2016 | Life Sciences

How to turn white fat brown

07.12.2016 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>